A taper is a planned drop, not a second drug
Prednisone taper charts, including week-by-week milligram drops, belong to a different drug. They are not printed on the prednisolone solution label or the Orapred ODT label. If a prescriber already wrote a short stop or a step-down, that written plan is the one to follow.
The solution label and the dissolving tablet do not share one starting range
| Product opened | Initial daily range on that label | How that label talks about stopping |
|---|---|---|
| TruPharma oral solution, 15 mg per 5 mL | 5 mg to 60 mg | Gradual decrease after more than a few days. Long-term therapy withdrawn gradually rather than abruptly. |
| Orapred ODT | 10 to 60 mg prednisolone base | After long-term therapy, withdraw gradually rather than abruptly. |
The oral solution label does not give a two-week or three-week permission to stop suddenly. Its gradual-decrease line is "more than a few days." Its abrupt-stop warning is for long-term therapy. It leaves the dose to the disease, the outlook, and how the person responds.
Orapred ODT, the prednisolone sodium phosphate dissolving tablet, uses the long-term wording too: after long-term therapy, withdraw gradually rather than abruptly. The oral solution label sets an initial range of 5 mg to 60 mg per day, depending on the disease. The Orapred ODT label sets an initial range of 10 to 60 mg of prednisolone base per day. A later taper step can sit below either starting range. An ODT tablet is still not a 5 mg piece to snap in half.
The risk sits in the months after the last dose, not only on the last morning
Gradual reduction is how the solution label says drug-induced secondary adrenocortical insufficiency may be minimized. That relative insufficiency may persist for months after the medicine is stopped. In any situation of stress during that period, the label says hormone therapy should be reinstituted. Restarting is a clinician decision. It is not an instruction to double whatever is left in the bottle.
During treatment, unusual stress has its own line. For unusual stress during corticosteroid therapy, the solution label says an increased dosage of a rapidly acting corticosteroid is indicated before, during, and after the stressful situation. Fever, injury, and an operation are the situations that line is about. The team needs the current dose. Skipping the dose on the way in because of illness creates a second problem beside the illness.
The same precaution says mineralocorticoid secretion may be impaired, and that salt and/or a mineralocorticoid should be given when that applies. That is clinic care. It is not a reason to add table salt at home.
Prednisone week charts do not transfer onto this bottle
Many taper explainers on the open web are written for prednisone or for steroids in general. Sample lines from those pages, including a patient-group suggestion to drop no more than 5 mg a week, are not instructions on the TruPharma or Orapred labels. Use the taper written on the prescription and the product in hand.
The Orapred comparison chart lists prednisone 10 mg beside prednisolone 10 mg for oral or intravenous dosing. The same chart says those relationships apply only to oral or intravenous administration. A milligram comparison is not a reason to copy a prednisone calendar onto a liquid, a different strength, or a tablet the label says not to divide.
Those dissolving tablets are friable and are not intended to be cut or split. The solution label tells the pharmacist to dispense a calibrated measuring device for the 15 mg/5 mL liquid. If the written step is a dose the blister cannot make, the prescriber picks a product that can be measured.
Infection is a reason to call, including when the label allows a reduction
Prednisolone oral solution suppresses the immune system and increases the risk of infection with viral, bacterial, fungal, protozoan, or helminthic pathogens. The label says corticosteroids can mask some signs of infection, so a quiet course is not proof the infection is small.
Systemic fungal infection is a contraindication to starting this solution. If a person already on chronic prednisolone oral solution develops a systemic fungal infection, the label recommends withdrawal or a dosage reduction, decided by the clinician treating that infection. That is the opposite of a cold stop chosen at the kitchen table the day a cough starts. Bring the bottle and the last week of doses.
What to put in front of the person who writes the steps
Bring the product name, the current daily amount, how long it has been taken, the date of the last change, and any fever, procedure, or new infection. The solution label says the severity, prognosis, expected duration of the disease, and the reaction to the medicine are primary factors in determining dosage. No landing dose is printed beside that sentence.
Condition-by-condition use is a different note, prednisolone uses. How the tablet was developed is prednisolone history. The access page is prednisolone.
The labels used here are the prednisolone oral solution DailyMed text and the Orapred ODT DailyMed text, both opened 24 October 2026.